Clinical Trials in Ohio

Showing 16841-16860 of 20,938 trials

Proximal Protection With The Mo.Ma Device During Carotid Stenting

NCT00744523

The objective of the ARMOUR study is to evaluate the safety and effectiveness of the Mo.Ma proximal flow blockage cerebral protection device for patients at high surgical risk for carotid endarterectomy who undergo carotid artery stenting

Carotid Artery Disease

Medtronic Endovascular262 participantsStarted Sep 2007

Buffalo, New York, United States • Columbus, Ohio, United States

COMPLETEDNA32 miles

GORE Flow Reversal System and GORE Embolic Filter Extension Study

NCT01343667

The objective of this study is to provide an ongoing evaluation of clinical outcomes associated with the GORE Flow Reversal System and the GORE Embolic Filter when used for embolic protection during carotid artery stenting.

Carotid StenosisConstriction, PathologicCarotid Artery Diseases+8 more

W.L.Gore & Associates1,397 participantsStarted Apr 2011

Flagstaff, Arizona, United States • Newport Beach, California, United States • San Francisco, California, United States +36 more locations

Proximal Protection With The Mo.Ma Device During Carotid Stenting

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Find Trials by Condition in Ohio

Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas

Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma

12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.

Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma

Lonafarnib in Metastatic Breast Cancer

Intradiscal rhGDF-5 Phase I/II Clinical Trial

Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days

Cervical Preparation Before Dilation and Evacuation

Safety of Gadovist in Renally Impaired Patients

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Study of an Investigational Glucose Meter System

Evaluation of the A1CNow+ Test Kit

Glucose Meter Study

Multi-site Decision Impact Study for Decipher